ambrisentan
Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. Ambrisentan was approved by the U.S. Food and Drug Administration (FDA) and European Medicines Agency, and designated an orphan drug, for the treatment of pulmonary hypertension. Reference standards of Ambrisentan API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Ambrisentan Acyl β-D-Glucuronide
[catalogue_number] => PA 28 46610
[category_ids] => ,80,95,71,76,75,78,70,82,
[chemical_name] =>
[weight] => 554.55
[form] => C28H30N20O10
[cas] => 1106685-58-8
[pslug] => 1106685-58-8-ambrisentan-acyl-beta-d-glucuronide-pa2846610
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Ambrisentan Acyl β-D-Glucuronide
Catalogue No.:PA 28 46610
Molecular Formula : C28H30N20O10
Molecular Weight : 554.55
stdClass Object
(
[pname] => (R,S)-Ambrisentan acyl-β-D-glucuronide
[catalogue_number] => PA 28 0461002
[category_ids] => ,70,75,76,78,82,95,
[chemical_name] =>
[weight] => 554.55
[form] => C28H30N2O10
[cas] => 1106685-82-8
[pslug] => 1106685-82-8-r-s-ambrisentan-acyl-beta-d-glucuronide-pa280461002
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
(R,S)-Ambrisentan acyl-β-D-glucuronide
Catalogue No.:PA 28 0461002
Molecular Formula : C28H30N2O10
Molecular Weight : 554.55
